-
公开(公告)号:US12215338B2
公开(公告)日:2025-02-04
申请号:US17053733
申请日:2019-05-08
Applicant: Neuracle Science Co., Ltd. , Neuracle Genetics
Inventor: Jong-Mook Kim , Dong Sik Kim , Juwon Shim , Soon-gu Kwon
Abstract: The present disclosure provides adeno-associated vims (AAV) vectors and uses thereof. In certain embodiments, the AAV vectors comprise a nucleic acid that encodes an antagonist against a family with sequence similarity 19, member A5 (FAM19A5) protein, e.g., anti-FAM19A5 antibody, e.g., anti-FAM19A5 scFv.
-
公开(公告)号:US12247070B2
公开(公告)日:2025-03-11
申请号:US17418681
申请日:2019-12-26
Applicant: NEURACLE SCIENCE CO., LTD.
Inventor: Bongcheol Kim , Dong Sik Kim , Jae-Keun Lee , Juwon Shim
Abstract: The present disclosure relates to the pharmaceutical use of antagonists (e.g., an antibody or antigen-binding portion thereof) that specifically bind to FAM19A5 to treat an atherosclerosis in a subject in need thereof.
-
3.
公开(公告)号:US11746149B2
公开(公告)日:2023-09-05
申请号:US16626630
申请日:2018-06-27
Applicant: Neuracle Science Co., Ltd.
Inventor: Bongcheol Kim , Dong Sik Kim , Soon-gu Kwon
IPC: A61K39/395 , A61K39/00 , C07K16/24
CPC classification number: C07K16/24 , C07K2317/565 , C07K2317/622 , C07K2317/76
Abstract: The present disclosure relates to the pharmaceutical use of antagonists (e.g., an antibody or antigen-binding portion thereof) that specifically bind to FAM19A5 to treat a glaucoma in a subject in need thereof.
-
公开(公告)号:US11634484B2
公开(公告)日:2023-04-25
申请号:US17050056
申请日:2019-04-24
Applicant: Neuracle Science Co., Ltd.
Inventor: Bongcheol Kim , Dong Sik Kim , Soon-Gu Kwon
Abstract: The present disclosure provides a method for the treatment of a neuropathic pain including a central neuropathic pain or a peripheral neuropathic pain in a subject comprising the administration of antibodies that specifically bind to human FAM19A5 and compositions comprising such antibodies. The present disclosure also provides methods for treating a neuropathic pain including a symptom of neuropathic pain, and/or an underlining cause of a neuropathic pain, by administering an antibody that specifically binds to human FAM19A5. In a specific aspect, the method comprises administering antibodies specifically bind to human FAM19A5, e.g., binds to soluble human FAM19A5 with a KD of 10 nM or less, or binds to membrane bound human FAM19A5 with a KD of 10 nM or less, or both, as measured by a method known in the art, e.g., ELISA.
-
公开(公告)号:US11618783B2
公开(公告)日:2023-04-04
申请号:US16626624
申请日:2018-06-27
Applicant: Neuracle Science Co., Ltd.
Inventor: Bongcheol Kim , Jae-Keun Lee , Dong Sik Kim , Junho Chung , Junyeong Jin
IPC: C07K16/00 , A61K39/395 , C07K16/24 , A61P35/00 , G01N33/50 , G01N33/574 , A61K39/00
Abstract: The present disclosure provides antibodies that specifically bind to human FAM19A5 and compositions comprising such antibodies. Also provided herein are methods for treating fibrosis or cancer using the anti-FAM19A5 antibodies.
-
公开(公告)号:US11155613B2
公开(公告)日:2021-10-26
申请号:US16626621
申请日:2018-06-27
Applicant: Neuracle Science Co., Ltd.
Inventor: Bongcheol Kim , Jae-Keun Lee , Dong Sik Kim
IPC: A61K39/00 , A61K39/395 , C07K16/24 , G01N33/68
Abstract: The present disclosure relates to the pharmaceutical use of antagonists (e.g., an antibody or antigen-binding portion thereof) that specifically bind to FAM19A5 to treat or to diagnose a fibrosis and/or a fibrosis-associated disease in a subject in need thereof.
-
公开(公告)号:US12077579B2
公开(公告)日:2024-09-03
申请号:US17475214
申请日:2021-09-14
Applicant: Neuracle Science Co., Ltd.
Inventor: Bongcheol Kim , Jae-Keun Lee , Dong Sik Kim
CPC classification number: C07K16/24 , G01N33/6863 , A61K2039/505 , C07K2317/21 , C07K2317/24 , C07K2317/565 , C07K2317/76
Abstract: The present disclosure relates to the pharmaceutical use of antagonists (e.g., an antibody or antigen-binding portion thereof) that specifically bind to FAM19A5 to treat or to diagnose a fibrosis and/or a fibrosis-associated disease in a subject in need thereof.
-
公开(公告)号:US11560425B2
公开(公告)日:2023-01-24
申请号:US16626625
申请日:2018-06-27
Applicant: Neuracle Science Co., Ltd.
Inventor: Bongcheol Kim , Eun Bee Cho , Dong Sik Kim , Jae-Keun Lee , Soon-gu Kwon , Jae Young Seong , Juwon Shim , Tae Woo Kim , Shin-hyuk Kang
Abstract: The present disclosure relates to the pharmaceutical use of antagonists (e.g., an antibody or antigen-binding portion thereof) that specifically bind to FAM19A5 to promote a blood vessel normalization and treat a disease (e.g., cancer) in a subject in need thereof, e.g., by promoting a blood vessel normalization.
-
-
-
-
-
-
-